首页> 外文期刊>Oncology letters >Post-operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non-urothelial recurrence and other clinical indicators
【24h】

Post-operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non-urothelial recurrence and other clinical indicators

机译:根治性肾结直肠癌切除术同侧膀胱袖带治疗上尿路尿路上皮癌患者的术后尿路上皮复发:与非尿路上皮复发及其他临床指标相比,预后影响最小

获取原文
获取原文并翻译 | 示例
       

摘要

Upper urinary tract urothelial carcinoma (UTUC) is a rare disease, and novel prognostic factors for patients who have undergone a radical nephroureterectomy (RNU) for UTUC have been studied intensely. To the best of our knowledge, the prognostic value of urothelial recurrence in patients with UTUC has not been previously described in studies. The present study compared the prognostic value of urothelial and non-urothelial recurrence in patients with UTUC of the kidney and ureter managed by surgery. The inclusion criteria consisted of a diagnosis of non-metastatic UTUC (any T stage, N0-1 and M0) and receipt of an RNU with an ipsilateral bladder cuff as the primary treatment. Of the 153 patients that were screened for the study, comprehensive clinical and pathological data was available for 103 patients, who were consequently included in the analysis. Overall survival (OS) and cancer-specific survival (CSS) times were estimated. A multivariate analysis was performed using the Cox regression model. The median follow-up period was 29 months (interquartile range, 14-63 months). The patient population was comprised of 71 males (68.9%) and 32 females (31.1%). A total of 32 patients (31.1%) showed non-urothelial recurrence, while 38 patients (36.9%) exhibited urothelial recurrence and 33 patients (32.0%) exhibited no recurrence. When comparing the risk parameters between the non-urothelial recurrence categories, the factors of pathological grade, microvascular invasion, lymphatic invasion and pT classification showed significant differences. However, there were no significant differences between the urothelial recurrence categories. No significant difference was observed between the OS and CSS times within the urothelial recurrence categories (P=0.3955 and P=0.05891, respectively), but significant differences were identified in the non-urothelial recurrence categories (P<0.0001 and P<0.0001, respectively). Among the other relevant descriptive pre-operative characteristics in the multivariate analysis, only non-urothelial recurrence remained associated with a worse CSS [P=0.002; hazard ratio (HR) 9.512]. The results show that urothelial recurrence has a minimal prognostic value in patients with UTUC managed by RNU with an ipsilateral bladder cuff.
机译:上尿路尿路上皮癌(UTUC)是一种罕见的疾病,对于接受UTUC根治性肾切除术(RNU)的患者,新的预后因素已得到了深入研究。据我们所知,先前尚未在研究中描述UTUC患者尿路上皮复发的预后价值。本研究比较了尿道上皮和非尿路上皮复发在通过手术治疗的肾脏和输尿管UTUC患者中的预后价值。纳入标准包括诊断为非转移性UTUC(任何T期,N0-1和M0),并接受以同侧膀胱套囊作为主要治疗的RNU。在筛选出的153例患者中,有103例患者的综合临床和病理学数据可用,因此将其纳入分析。估计了总生存时间(OS)和癌症特异性生存时间(CSS)。使用Cox回归模型进行多元分析。中位随访期为29个月(四分位间距为14-63个月)。患者人群包括71名男性(68.9%)和32名女性(31.1%)。共有32例(31.1%)表现为非尿路上皮复发,而38例(36.9%)表现为尿路上皮复发,而33例(32.0%)没有复发。在比较非尿路上皮复发类别之间的风险参数时,病理分级,微血管浸润,淋巴管浸润和pT分类的因素显示出显着差异。但是,尿路上皮复发类别之间没有显着差异。在尿路上皮复发类别中,OS和CSS时间之间没有观察到显着差异(分别为P = 0.3955和P = 0.05891),但在非尿路上皮复发类别中则发现了显着差异(分别为P <0.0001和P <0.0001) )。在多变量分析中其他相关的描述性术前特征中,仅非尿路上皮复发仍与较差的CSS相关[P = 0.002;危险比(HR)9.512]。结果表明,尿路上皮复发对具有同侧膀胱袖带的RNU治疗的UTUC患者的预后价值最小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号